Literature DB >> 26693507

The dynamic interactome of human Aha1 upon Y223 phosphorylation.

Donald Wolfgeher1, Diana M Dunn2, Mark R Woodford3, Dimitra Bourboulia2, Gennady Bratslavsky3, Mehdi Mollapour2, Stephen J Kron1, Andrew W Truman4.   

Abstract

Heat Shock Protein 90 (Hsp90) is an essential chaperone that supports the function of a wide range of signaling molecules. Hsp90 binds to a suite of co-chaperone proteins that regulate Hsp90 function through alteration of intrinsic ATPase activity. Several studies have determined Aha1 to be an important co-chaperone whose binding to Hsp90 is modulated by phosphorylation, acetylation and SUMOylation of Hsp90 [1], [2]. In this study, we applied quantitative affinity-purification mass spectrometry (AP-MS) proteomics to understand how phosphorylation of hAha1 at Y223 altered global client/co-chaperone interaction [3]. Specifically, we characterized and compared the interactomes of Aha1-Y223F (phospho-mutant form) and Aha1-Y223E (phospho-mimic form). We identified 99 statistically significant interactors of hAha1, a high proportion of which (84%) demonstrated preferential binding to the phospho-mimic form of hAha1. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository [4] with the dataset identifier PXD001737.

Entities:  

Keywords:  Aha1; Cancer; Chaperones; Co-chaperones; Hsp90; Interactome; Phosphorylation; Proteomics

Year:  2015        PMID: 26693507      PMCID: PMC4659802          DOI: 10.1016/j.dib.2015.10.028

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications table

Value of the data This data provides a comprehensive interactome of human Aha1. This study examines the Aha1 interactome quantitatively ±Y223 phosphorylation. Identifies important client and co-chaperone proteins that are specifically altered by Y223 phosphorylation. Demonstrates a novel method for regulating Hsp90 function, a key molecule in cancer proliferation.

Experimental design, materials and methods

HEK293 cell lines expressing either hAha1Y223F–FLAG or Y223E–FLAG were grown in Dulbecco׳s modified Eagle׳s minimal essential medium (DMEM, Invitrogen) supplemented with 10% fetal bovine serum [1], [2], [3], [4]. All cell lines were propagated at 37 °C in an atmosphere containing 5% CO2. Protein extraction from both HEK293 cells was carried out using methods previously described [5]. For immunoprecipitation, mammalian cell lysates were incubated with anti-FLAG antibody conjugated magnetic beads (Sigma) for 2 h at 4 °C and washed 4 times with fresh lysis buffer (20 mM Tris (pH 7.5), 100 mM NaCl, 1 mM MgCl2, 0.1% NP40, Protease and Phosphatase inhibitor mini tablet, EDTA-free (Pierce). hAha1 complexes were eluted with FLAG peptide (Apex Bio).

LC–MS/MS data acquisition

Trypsin digestion of hAha1–FLAG complexes from SDS-PAGE gels

After hAha1 complexes were obtained, samples were processed as in [6], [7]. Purified hAha1Y223F–FLAG or Y223E–FLAG complexes were loaded onto a 12% MOPS buffered SDS-PAGE gel (Invitrogen) and run for 10 min at 200 v resulting in a ~2 cm “gel plug”. The gel was stained with 25 mL Imperial Stain (Pierce) at room temperature, and destained overnight in dH2O at 4 °C. The gel plugs for each sample to be analyzed were excised by sterile razor blade, divided into 2 sections ~1 cm each, and chopped into ~1 mm3 pieces. Each section was washed in dH2O and destained using 100 mM NH4HCO3 pH 7.5 in 50% acetonitrile. A reduction step was performed by addition of 100 μl 50 mM NH4HCO3 pH 7.5 and 10 μl of 200 mM tris (2-carboxyethyl) phosphine HCl at 37 °C for 30 min. The proteins were alkylated by addition of 100 μl of 50 mM iodoacetamide prepared fresh in 50 mM NH4HCO3 pH 7.5 buffer, and allowed to react in the dark at 20 °C for 30 min. Gel sections were washed in water, then acetonitrile, and vacuum dried. Trypsin digestion was carried out overnight at 37 °C with 1:50–1:100 enzyme–protein ratio of sequencing grade-modified trypsin (Promega) in 50 mM NH4HCO3 pH 7.5, and 20 mM CaCl2. Peptides were extracted with 5% formic acid and vacuum dried.

Isotopic labeling of trypsin-digested hAha1–FLAG complexes

Peptide digests were reconstituted with 70 μl of TrisHCl buffer solution (10 mM of TrisHCl, 150 mM NaCl, 20 mM CaCl2, pH 7.6), vortexed for at least 20 min to reconstitute the peptide mixture, then split into two vials of 30 μl each (16O vial and 18O vial), and 10 μl was retained unlabeled and stored in −80 °C. In a separate vial Mag-Trypsin beads (Clontech) were prepared as follows. 30 μl Mag-trypsin beads per rxn (16O or 18O) were pooled and washed 3 times with 800 μl of TrisHCl Buffer Solution, then brought back up in 30 μl/sample of TrisHCl buffer, and aliquoted to a new 1.5 ml vial in the quantity of 30 μl, vortexing lightly after each aliquot to keep the Mag-trypsin beads in suspension. Using a magnetic rack, the TrisHCl buffer was removed from the beads, and the 30 μl of sample digest from above was added to the beads and vacuum dried. 30 μl of either 16O H2O or 97% 18O H2O (Cambridge Isotopes Laboratories) was added to the respective 16O or 18O prepared Mag-Trypsin bead vial and vortexed for 20 min to reconstitute the peptide mixture, and allowed to exchange overnight at 37 °C. After 18O exchange, the solution was transferred to a new vial and any free trypsin in solution was inactivated with 1 mM PMSF for 30 min at 4 °C. For each sample section, the AHA-1 (E/F) digests were combined 1:1 as follows: Forward (FWD) Sample Set: (F)-16O:(E)-18O and Reversed (REV) Sample Set: (E)-16O:(F)-18O, dried and stored at −80 °C until analysis. Three biological replicate experiments were performed.

HPLC for mass spectrometry

All samples were re-suspended in Burdick & Jackson HPLC-grade water containing 0.2% formic acid (Fluka), 0.1% TFA (Pierce), and 0.002% Zwittergent 3–16 (Calbiochem), a sulfobetaine detergent that contributes the following distinct peaks at the end of chromatograms: MH+ at 392, and in-source dimer [2M+H+] at 783, and some minor impurities of Zwittergent 3–12 seen as MH+ at 336. The peptide samples were loaded to a 0.25 μl C8 OptiPak trapping cartridge custom-packed with Michrom Magic (Optimize Technologies) C8, washed, then switched in-line with a 20 cm by 75 μm C18 packed spray tip nanocolumn packed with Michrom Magic C18AQ, for a 2-step gradient. Mobile phase A was water/acetonitrile/formic acid (98/2/0.2) and mobile phase B was acetonitrile/isopropanol/water/formic acid (80/10/10/0.2). Using a flow rate of 350 nl/min, a 90 min, 2-step LC gradient was run from 5% B to 50% B in 60 min, followed by 50–95% B over the next 10 min, hold 10 min at 95% B, back to starting conditions and re-equilibrated.

LC–MS/MS analysis

The samples were analyzed via electrospray tandem mass spectrometry (LC–MS/MS) on a Thermo Q-Exactive Orbitrap mass spectrometer, using a 70,000 RP survey scan in profile mode, m/z 360–2000 Da, with lockmasses, followed by 10 MSMS HCD fragmentation scans at 17,500 resolution on doubly and triply charged precursors. Single charged ions were excluded, and ions selected for MS/MS were placed on an exclusion list for 60 s.

LC–MS/MS data analysis, statistical analysis

All LC–MS/MS *.raw Data files were analyzed with MaxQuant version 1.2.2, searching against the SPROT Human database using the following criteria: 18O heavy label was selected for quantitation with a min of 1 high confidence peptide to assign quantitation H/L ratio. Trypsin was selected as the protease with max miss cleavage set to 2. Carbamiodomethyl (C) was selected as a fixed modification. Variable modifications were set to Oxidization (M), Formylation (n-term), and Phosphorylation (STY). Orbitrap mass spectrometer was selected using an MS error of 20 ppm and a MS/MS error of 0.5 Da. 1% FDR cutoff was selected for peptide, protein, and site identifications. Ratios were reported based on the MS level light and heavy peak areas determined by MaxQuant and reported in the proteinGroups.txt file as heavy/light or (hAha1Y223E/hAha1Y223F mutant). Proteins were removed from this results file if they were flagged by MaxQuant as “Contaminants”, “Reverse” or “Only identified by site”. Complete three biological replicates were performed, with each biological replicate split into two technical replicates (18O forward (FWD) labeling, and 18O reverse (REV) labeling). The abundance data from each biological replicate were normalized to the ratio of the bait protein in that run (e.g. normalized to the hAHA1–FLAG ratio). Light and Heavy peak intensities were analyzed in each run to determine protein hits that fell into the category of either hAha1Y223E-only hits or hAha1Y223F-only hits and retained if they confirmed to this state across all 6 runs. In the case of hAha1Y223E-only or hAha1Y223F-only protein hits, spectra counts can be used as a proxy for abundance as these would not of been assigned a quantitation ratio. This produced a list of hAha1 interactors and their respective quantitated changes between hAha1Y223F and hAha1Y223E. Further statistical analysis was performed using the R statistical package (http://www.r-project.org/). Proteins with three out of the six observations were retained. Missing values were imputed using row mean imputation. An ANOVA test was then performed to identify proteins that indicate significant variability (P-value<0.05) between biological replicates within each group. The mass spectrometry proteomic data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (REF A) with the dataset identifier PXD001737.
Subject areaBiology
More specific subject areaMolecular chaperones, Mass spectrometry, phosphorylation
Type of data18O Quant LC–MS/MS Mass spectrometry data
How data was acquiredMass spectrometry. Thermo Q-Exactive Orbitrap
Data format*.Raw
Experimental factorsHEK293 cells expressing either FLAG–hAha1–Y223E or FLAG–Aha1–Y223F
Experimental featuresFLAG–hAha1–Y223E or FLAG–Aha1–Y223F complexes were purified by magnetic bead immunoprecipitation and processed by mass spectrometry
Data source locationThe University of Chicago, Chicago, Illinois, USA
Data accessibilityThe mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset identifier PXD001737.
  7 in total

1.  Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine.

Authors:  Wanping Xu; Mehdi Mollapour; Chrisostomos Prodromou; Suiquan Wang; Bradley T Scroggins; Zach Palchick; Kristin Beebe; Marco Siderius; Min-Jung Lee; Anthony Couvillon; Jane B Trepel; Yoshihiko Miyata; Robert Matts; Len Neckers
Journal:  Mol Cell       Date:  2012-06-21       Impact factor: 17.970

2.  Detecting HSP90 phosphorylation.

Authors:  Mehdi Mollapour; Len Neckers
Journal:  Methods Mol Biol       Date:  2011

3.  Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors.

Authors:  Mehdi Mollapour; Dimitra Bourboulia; Kristin Beebe; Mark R Woodford; Sigrun Polier; Anthony Hoang; Raju Chelluri; Yu Li; Ailan Guo; Min-Jung Lee; Elham Fotooh-Abadi; Sahar Khan; Thomas Prince; Naoto Miyajima; Soichiro Yoshida; Shinji Tsutsumi; Wanping Xu; Barry Panaretou; William G Stetler-Stevenson; Gennady Bratslavsky; Jane B Trepel; Chrisostomos Prodromou; Len Neckers
Journal:  Mol Cell       Date:  2014-01-23       Impact factor: 17.970

4.  Quantitative proteomics of the yeast Hsp70/Hsp90 interactomes during DNA damage reveal chaperone-dependent regulation of ribonucleotide reductase.

Authors:  Andrew W Truman; Kolbrun Kristjansdottir; Donald Wolfgeher; Natalia Ricco; Anoop Mayampurath; Samuel L Volchenboum; Josep Clotet; Stephen J Kron
Journal:  J Proteomics       Date:  2014-10-18       Impact factor: 4.044

5.  The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013.

Authors:  Juan Antonio Vizcaíno; Richard G Côté; Attila Csordas; José A Dianes; Antonio Fabregat; Joseph M Foster; Johannes Griss; Emanuele Alpi; Melih Birim; Javier Contell; Gavin O'Kelly; Andreas Schoenegger; David Ovelleiro; Yasset Pérez-Riverol; Florian Reisinger; Daniel Ríos; Rui Wang; Henning Hermjakob
Journal:  Nucleic Acids Res       Date:  2012-11-29       Impact factor: 16.971

6.  CDK-dependent Hsp70 Phosphorylation controls G1 cyclin abundance and cell-cycle progression.

Authors:  Andrew W Truman; Kolbrun Kristjansdottir; Donald Wolfgeher; Naushaba Hasin; Sigrun Polier; Hong Zhang; Sarah Perrett; Chrisostomos Prodromou; Gary W Jones; Stephen J Kron
Journal:  Cell       Date:  2012-12-07       Impact factor: 41.582

7.  c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells.

Authors:  Diana M Dunn; Mark R Woodford; Andrew W Truman; Sandra M Jensen; Jacqualyn Schulman; Tiffany Caza; Taylor C Remillard; David Loiselle; Donald Wolfgeher; Brian S J Blagg; Lucas Franco; Timothy A Haystead; Soumya Daturpalli; Matthias P Mayer; Jane B Trepel; Rhodri M L Morgan; Chrisostomos Prodromou; Stephen J Kron; Barry Panaretou; William G Stetler-Stevenson; Steve K Landas; Len Neckers; Gennady Bratslavsky; Dimitra Bourboulia; Mehdi Mollapour
Journal:  Cell Rep       Date:  2015-07-30       Impact factor: 9.423

  7 in total
  5 in total

1.  O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.

Authors:  Elena V Efimova; Oliver K Appelbe; Natalia Ricco; Steve S-Y Lee; Yue Liu; Donald J Wolfgeher; Tamica N Collins; Amy C Flor; Aishwarya Ramamurthy; Sara Warrington; Vytautas P Bindokas; Stephen J Kron
Journal:  Mol Cancer Res       Date:  2019-03-18       Impact factor: 5.852

Review 2.  Not quite the SSAme: unique roles for the yeast cytosolic Hsp70s.

Authors:  Sarah K Lotz; Laura E Knighton; Gary W Jones; Andrew W Truman
Journal:  Curr Genet       Date:  2019-04-24       Impact factor: 3.886

Review 3.  Oligomerization of Hsp70: Current Perspectives on Regulation and Function.

Authors:  Jade E Takakuwa; Laura E Knighton; Andrew W Truman
Journal:  Front Mol Biosci       Date:  2019-09-04

4.  Rapid deacetylation of yeast Hsp70 mediates the cellular response to heat stress.

Authors:  Linan Xu; Naushaba Hasin; Daragh D Cuskelly; Donald Wolfgeher; Sean Doyle; Paul Moynagh; Sarah Perrett; Gary W Jones; Andrew W Truman
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

5.  The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma.

Authors:  Michael Heider; Ruth Eichner; Jacob Stroh; Volker Morath; Anna Kuisl; Jana Zecha; Jannis Lawatscheck; Kheewoong Baek; Anne-Kathrin Garz; Martina Rudelius; Friedrich-Christian Deuschle; Ulrich Keller; Simone Lemeer; Mareike Verbeek; Katharina S Götze; Arne Skerra; Wolfgang A Weber; Johannes Buchner; Brenda A Schulman; Bernhard Kuster; Vanesa Fernández-Sáiz; Florian Bassermann
Journal:  Mol Cell       Date:  2021-02-10       Impact factor: 17.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.